EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

COMPARATIVE EFFICACY AND SAFETY OF ANTICOAGULATION STRATEGIES FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES

Angga Rifqi Mujidiatama, Muhammad Ogan Islakhul Idham, Azatil Ishmah Matdoan, Juchairah Faradillah Sangadji, Jansen Hadinata Soetanto

The Indonesian Journal of General Medicine · 15.11.2026 · 44 (2) · 542-611

DOI: 10.70070/ge1nhe61 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Indonesian Journal of General Medicine, online erschienen am 15.11.2026. Verfasst von Angga Rifqi Mujidiatama und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Electrical cardioversion (ECV) is the most effective method for restoring sinus rhythm in atrial fibrillation (AF), but it transiently amplifies the risk of thromboembolism through atrial stunning and a post-conversion prothrombotic state. Several anticoagulation strategies coexist in contemporary practice: dose-adjusted vitamin K antagonists (VKA) with or without heparin bridging, non-vitamin K antagonist oral anticoagulants (NOAC), imaging-guided early versus conventional delayed cardioversion, and, in acute-onset AF, cardioversion without periprocedural anticoagulation. Their comparative efficacy and safety have not been integrated within a single quantitative framework that combines randomized and real-world evidence. We therefore aimed to compare these strategies with respect to thromboembolism, bleeding, mortality, and pre-cardioversion left atrial thrombus.

Methods

The study strictly adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. PubMed, Europe PMC, Google Scholar, Semantic Scholar, and ClinicalTrials.gov were searched for reports published between January 2011 and October 2026. Randomized controlled trials (RCTs), RCT-derived cardioversion analyses, comparative cohort studies, and case series of adults undergoing ECV for AF or atrial flutter were eligible. Risk of bias was assessed with RoB 2, ROBINS-I, and the JBI checklist for case series. Risk ratios (RR) were pooled with DerSimonian–Laird random-effects models, complemented by Mantel–Haenszel fixed-effect, Peto, and Hartung–Knapp–Sidik–Jonkman (HKSJ) analyses with prediction intervals; adjusted estimates were pooled by generic inverse variance and single-arm incidences by the Freeman–Tukey transformation. Certainty of evidence was graded with GRADE.

Results

Thirty-five studies (42 reports) were included: 8 RCTs or RCT-derived analyses, 20 comparative cohorts, and 7 case series, encompassing 93,271 patients or cardioversion procedures. Compared with VKA, NOAC-based anticoagulation yielded a similar risk of stroke or systemic embolism (RR 0.90; 95% CI 0.65–1.26; 18 studies; I² = 0%), with a numerically lower estimate in randomized evidence (RR 0.60; 95% CI 0.27–1.35). Major bleeding was reduced (RR 0.66; 95% CI 0.45–0.96; 17 studies; absolute difference -1.6 per 1,000 cardioversions), a benefit driven by observational cohorts and attenuated in randomized trials (RR 0.91; 95% CI 0.49–1.70). In dedicated cardioversion RCTs, the trial-defined efficacy composite was lower with NOAC (RR 0.43; 95% CI 0.21–0.87), and ischaemic stroke was reduced (RR 0.10; 95% CI 0.01–0.77; 2 RCTs). All-cause mortality did not differ (RR 0.74; 95% CI 0.32–1.68). Treatment effects were consistent across early/transoesophageal echocardiography (TEE)-guided and delayed strategies (P for interaction = 0.80), individual NOACs (P = 0.38), and prior anticoagulant exposure (P = 0.55). Imaging-guided/early cardioversion was not associated with different thromboembolic risk compared with conventional delayed cardioversion (RR 0.88; 95% CI 0.41–1.90). Periprocedural oral anticoagulation, compared with none, reduced thromboembolism by 63% (RR 0.37; 95% CI 0.28–0.49; 7 studies; I² = 0%). Pooled post-cardioversion thromboembolic incidence was 0.17% with NOAC, 0.32% with VKA, and 0.45% without anticoagulation. Certainty of evidence ranged from low to very low.

Discussion

NOAC-based strategies provide thromboembolic protection at least equivalent to well-managed VKA during ECV, with a favourable but design-dependent bleeding signal and practical advantages that permit earlier cardioversion. The protective effect of periprocedural anticoagulation is large and consistent, including in acute-onset AF, whereas the choice between imaging-guided early and conventional delayed timing does not appear to modify thromboembolic risk when therapeutic anticoagulation is ensured.

Conclusion

Uninterrupted therapeutic anticoagulation, preferably with a NOAC, should accompany every electrical cardioversion of AF irrespective of AF duration in patients with thromboembolic risk factors, either for at least 3 weeks before cardioversion or with imaging exclusion of left atrial thrombus, and for at least 4 weeks afterwards. Adequately powered randomized trials of strategy timing, reduced-dose regimens, and acute-onset AF are still required.

Zitieren

APA

Mujidiatama, A. R., Idham, M. O. I., Matdoan, A. I., Sangadji, J. F., & Soetanto, J. H. (2026). COMPARATIVE EFFICACY AND SAFETY OF ANTICOAGULATION STRATEGIES FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES. The Indonesian Journal of General Medicine, 44(2), 542-611. https://doi.org/10.70070/ge1nhe61

Vancouver

Mujidiatama AR, Idham MOI, Matdoan AI, Sangadji JF, Soetanto JH. COMPARATIVE EFFICACY AND SAFETY OF ANTICOAGULATION STRATEGIES FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES. The Indonesian Journal of General Medicine. 2026;44(2):542-611. doi:10.70070/ge1nhe61

BibTeX
@article{Mujidiatama2026,
  author = {Mujidiatama, Angga Rifqi and Idham, Muhammad Ogan Islakhul and Matdoan, Azatil Ishmah and Sangadji, Juchairah Faradillah and Soetanto, Jansen Hadinata},
  title = {COMPARATIVE EFFICACY AND SAFETY OF ANTICOAGULATION STRATEGIES FOR ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES},
  journal = {The Indonesian Journal of General Medicine},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {542--611},
  doi = {10.70070/ge1nhe61}
}
Kostenlos starten →